References
Bartlett JG: Anaerobic cocci. In: Mandell GL, Douglas RG Jr, Bennett JE (ed): Principles and practice of infectious diseases. Churchill Livingstone, New York, 1990, p. 1867–1869.
Wilson WR, Martin WJ, Wilkoske CJ, Washington JA II: Anaerobic bacteremia. Mayo Clinic Proceedings 1972, 47: 639–646.
Brook I: Anaerobic bacterial bacteremia: 12-year experience in two military hospitals. Journal of Infectious Diseases 1989, 160: 1071–1075.
Lombardi DP, Engleberg NC: Anaerobic bacteremia: incidence, patient characteristics, and clinical significance. American Journal of Medicine 1992, 92: 53–60.
Singh N, Yu VL: Osteomyelitis due toVeillonella parvula: case report and review. Clinical Infectious Diseases 1992, 14: 361–363.
Beumont MG, Duncan J, Mitchell SD, Esterhai JL Jr, Edelstein PH:Veillonella myositis in an immunocompromised patient. Clinical Infectious Diseases 1995, 21: 678–679.
Fisher RG, Denison MR:Veillonella parvula bacteremia without an underlying source. Journal of Clinical Microbiology 1996, 34: 3235–3236.
National Committee for Clinical Laboratory Standards: Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard M11-A3. NCCLS, Villanova, PA, 1993.
National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. Approved standard M100-S6. NCCLS, Villanova, PA, 1995.
Rolfe RD, Finegold SM: Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria. Antimicrobial Agents and Chemotherapy 1981, 20: 600–609.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liu, J.W., Wu, J.J., Wang, L.R. et al. Two fatal cases ofVeillonella bacteremia. Eur. J. Clin. Microbiol. Infect. Dis. 17, 62–64 (1998). https://doi.org/10.1007/BF01584370
Issue Date:
DOI: https://doi.org/10.1007/BF01584370